Our partner is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to address the unmet medical needs of patients with life-threatening viral diseases. Their medicinal chemistry and virology expertise, bolstered by their collective experience in drug development, is enabling them to pioneer new advancement in antiviral science. Leveraging the power of their medicinal chemistry expertise and purine nucleotide prodrug platform, they are focused on discovering, optimizing, and rapidly advancing novel drug candidates for viral target such as SARS CoV-2.

This critical hire provided leadership and drove the quality management process for the company. This included management and oversight in support of all development and manufacturing activities, directed cGxP quality related activities across the organization to support global regulatory submissions (NDA/MAA, etc.) and ultimately, commercial launch of products.